Senores Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2025
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted a routine compliance certificate to the stock exchanges under SEBI's Depositories Regulations for the quarter ending September 30, 2025. This certificate, filed by the company's Registrar and Share Transfer Agent, confirms the reconciliation of share holdings held in dematerialized (demat) form with the company's records. Every listed company with demat shares is required to file this certificate on a quarterly basis. There is no change in share capital, business, or ownership involved in this filing.
This is a standard, routine compliance filing with no bearing on the company's financials, operations, or stock price. Investors can safely ignore this announcement as it carries no material information.